XML 61 R44.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Fair Value of Options Granted
The fair value of each option granted under the Plan was estimated on the date of grant using the Black-Scholes valuation model that uses the following weighted-average assumptions:
Year Ended
December 31, 2025December 31, 2024December 31, 2023
Expected option term (in years)6.56.56.5
Expected volatility factor32 %32 %32 %
Weighted-average risk-free interest rate4.39 %4.33 %3.90 %
Expected dividend rate1.0 %1.0 %1.2 %
Schedule of Stock Options Activity
A summary of stock option activity during the years ended December 31, 2025, 2024, and 2023 is as follows:
Year Ended
December 31, 2025December 31, 2024December 31, 2023
SharesWeighted Avg. Exercise PriceSharesWeighted Avg. Exercise PriceSharesWeighted Avg. Exercise Price
Number of shares under options:
Outstanding at beginning of period914,583 $18.72 2,089,493 $14.67 2,647,578 $13.75 
Granted66,540 35.47 93,410 31.05 146,295 22.25 
Exercised (1)(401,017)13.95 (1,241,512)12.62 (655,644)11.66 
Canceled/Forfeited(30,434)26.62 (26,808)28.49 (48,736)27.77 
Outstanding at end of period (2)549,672 $23.80 914,583 $18.72 2,089,493 $14.67 
Exercisable at end of period (3)407,617 $21.14 747,808 $16.71 1,878,789 $13.35 
______________________
(1)The total intrinsic value of options exercised during the years ended December 31, 2025, 2024, and 2023 was $11.5 million, $29.3 million and $11.0 million, respectively.
(2)The weighted average remaining contractual life of options outstanding was 5.5 years at December 31, 2025, 4.8 years at December 31, 2024 and 4.1 years at December 31, 2023. The aggregate intrinsic value of options outstanding at December 31, 2025 was $12.4 million.
(3)The weighted average remaining contractual life of options exercisable was 4.5 years at December 31, 2025, 3.9 years at December 31, 2024 and 3.4 years at December 31, 2023. The aggregate intrinsic value of options exercisable at December 31, 2025 was $10.3 million.
SharesWeighted Avg. Exercise Price
Nonvested options at beginning of period166,775 $27.77 
Granted66,540 35.47 
Vested(71,876)27.03 
Canceled/Forfeited(19,384)29.92 
Nonvested options at end of period142,055 $31.41 
Schedule of Restricted Stock Units Activity A summary of RSU activity during the years ended December 31, 2025, 2024, and 2023 is as follows:
Year Ended
December 31, 2025December 31, 2024December 31, 2023
UnitsWeighted Avg. Grant Date Fair ValueUnitsWeighted Avg. Grant Date Fair ValueUnitsWeighted Avg. Grant Date Fair Value
Nonvested RSUs at beginning of period263,075 $26.97 501,321 $26.05 580,112 $29.33 
Granted198,393 35.71 125,565 31.23 242,385 23.40 
Vested(165,527)29.29 (318,274)27.06 (218,153)30.70 
Canceled/Forfeited(29,882)31.02 (45,537)27.30 (103,023)28.40 
Nonvested RSUs at end of period266,059 $31.70 263,075 $26.97 501,321 $26.05 
Schedule of Nonvested Performance-based Units Activity A summary of PSU activity during the years ended December 31, 2025, 2024, and 2023 is as follows:
Year Ended
December 31, 2025December 31, 2024December 31, 2023
UnitsWeighted Avg. Grant Date Fair ValueUnitsWeighted Avg. Grant Date Fair ValueUnitsWeighted Avg. Grant Date Fair Value
Nonvested PSUs at beginning of period945,741 $29.53 866,810 $27.88 939,459 $27.07 
Granted395,700 35.64 553,548 34.33 425,246 23.25 
Vested (1)(402,020)23.25 (431,702)32.25 (468,722)22.17 
Canceled/Forfeited(10,528)33.00 (42,915)30.91 (29,173)26.07 
Nonvested PSUs at end of period928,893 $34.81 945,741 $29.53 866,810 $27.88 
______________________
(1)For the years ended December 31, 2025, 2024, and 2023, represents the target level of PSUs vested.